| Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome. | |
| | |
MedLine Citation:
|
PMID: 21412918 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Intrapartum pharyngeal instillation of surfactant before the first breath may result in surfactant administration to the infant lung, with the potential benefit of avoiding endotracheal intubation and ventilation, ventilator induced lung injury and bronchopulmonary dysplasia. OBJECTIVES: To determine the effect of pharyngeal instillation of surfactant before the first breath compared to placebo, no treatment or intratracheal surfactant administration followed by intermittent positive pressure ventilation (IPPV) on morbidity and mortality in preterm infants at risk of respiratory distress syndrome (RDS). SEARCH STRATEGY: Searches were made of CENTRAL (The Cochrane Library, to September 2010), MEDLINE and PREMEDLINE (1950 to September 2010), EMBASE (1980 to 2010) and CINAHL (1982 to 2010). This strategy was supplemented by searches of proceedings of scientific meetings, Google Scholar and reference lists of identified studies, as well as contact with expert informants and surfactant manufacturers. SELECTION CRITERIA: Published, unpublished and ongoing randomised controlled or quasi-randomised trials (using individual or cluster allocation) of pharyngeal instillation of surfactant before the first breath compared to placebo or no treatment, or intratracheal surfactant instillation followed by IPPV, on morbidity and mortality in preterm infants at risk of RDS. DATA COLLECTION AND ANALYSIS: Two authors independently assessed study eligibility and quality. MAIN RESULTS: No published, unpublished or ongoing trials that met the inclusion criteria for this review were found. AUTHORS' CONCLUSIONS: There were no data from randomised controlled or quasi-randomised trials that evaluated the effect of intrapartum instillation of pharyngeal surfactant before the first breath. Evidence from animal and observational human studies suggest that pharyngeal instillation of surfactant before the first breath is potentially safe, feasible and may be effective. Well designed trials are needed. |
| | |
Authors:
|
Mohamed E Abdel-Latif; David A Osborn |
Related Documents
:
|
10671328 - Invasive disease due to group b streptococcus in pregnant women and neonates from diver... 20670228 - Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of an... 15295698 - Level of maternal igg anti-group b streptococcus type iii antibody correlated with prot... 16140198 - An adenosine a2a receptor agonist reduces interleukin-8 expression and glycosaminoglyca... 7400728 - The plight of female infants in india. 9853918 - Surfactant protein-c in ventilated premature lamb lung. |
Publication Detail:
|
Type: Journal Article; Review Date: 2011-03-16 |
Journal Detail:
|
Title: Cochrane database of systematic reviews (Online) Volume: - ISSN: 1469-493X ISO Abbreviation: Cochrane Database Syst Rev Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-03-17 Completed Date: 2011-04-01 Revised Date: 2011-06-16 |
Medline Journal Info:
|
Nlm Unique ID: 100909747 Medline TA: Cochrane Database Syst Rev Country: England |
Other Details:
|
Languages: eng Pagination: CD008311 Citation Subset: IM |
Affiliation:
|
Department of Neonatology, Australian National University Medical School, PO Box 11, Woden, ACT, Australia, 2606. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Humans Infant, Newborn Infant, Premature Instillation, Drug Pharynx Pulmonary Surfactants / administration & dosage* Respiration* Respiratory Distress Syndrome, Newborn / prevention & control* |
| Chemical | |
Reg. No./Substance:
|
0/Pulmonary Surfactants |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Intratympanic gentamicin for Ménière's disease or syndrome.
Next Document: Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to ...